Author

L. Wang

OpenAlex ID: A5040908287

S201: Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (r/r Chl)

2022 · C. Carlo-Stella, S. Ansell, et al. · HemaSphere · 13

Camidanlumab Tesirine Efficacy and Safety in an Open‐label, Multicenter, Phase 2 Study of Patients (pts) With Relapsed or Refractory Classical Hodgkin Lymphoma (r/r Chl)

2021 · P. L. Zinzani, C. Carlo‐Stella, et al. · Hematological Oncology · 4

Lotis‐5, an Ongoing Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab (lonca‐r) Versus Immunochemotherapy in Patients With R/r Dlbcl

2023 · C. Carlo‐Stella, M. Kwiatek, et al. · Hematological Oncology · 2

Works count: 3

Citation count: 19

H-index: 2

I10-index: 1